학술논문
Pharmacokinetics, safety, and tolerability of four 28-day cycle intramuscular injections for risperidone-ISM 75 mg in patients with schizophrenia: A phase-2 randomized study (PRISMA-2)
Document Type
Abstract
Author
Source
In European Psychiatry March 2016 33 Supplement:S240-S241
Subject
Language
ISSN
0924-9338